Twist bioscience and ginkgo bioworks sign new collaboration

South san francisco, calif. & boston--(business wire)--twist bioscience corporation (nasdaq: twst), a company enabling customers to succeed through its offering of high-quality synthetic dna using its silicon platform, and ginkgo bioworks (nyse: dna), the leading horizontal platform for cell programming, today announced a new supply agreement expanding the depth and breadth of the collaboration between two of the leading organizations in the synthetic biology ecosystem. the four-year agreement
DNA Ratings Summary
DNA Quant Ranking